{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T05:07:36Z","timestamp":1768540056031,"version":"3.49.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T00:00:00Z","timestamp":1467244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T00:00:00Z","timestamp":1467244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hyperglycemia, the condition of high blood glucose, is typical of diabetes and obesity and represents a significant clinical problem. The relationship between hyperglycemia and cancer risk has been established by several studies. Moreover, hyperglycemia has been shown to reduce cancer cell response to therapies, conferring resistance to drug-induced cell death. Therefore, counteracting the negative effects of hyperglycemia may positively improve the cancer cell death induced by chemotherapies. Recent studies showed that zinc supplementation may have beneficial effects on glycemic control. Here we aimed at evaluating whether ZnCl<jats:sub>2<\/jats:sub> could counteract the high-glucose (HG) effects and consequently restore the drug-induced cancer cell death. At the molecular level we found that the HG-induced expression of genes known to be involved in chemoresistance (such as HIF-1<jats:italic>\u03b1<\/jats:italic>, GLUT1, and HK2 glycolytic genes, as well as NF-<jats:italic>\u03ba<\/jats:italic>B activity) was reduced by ZnCl<jats:sub>2<\/jats:sub> treatment. In agreement, the adryamicin (ADR)-induced apoptotic cancer cell death was significantly impaired by HG and efficiently re-established by ZnCl<jats:sub>2<\/jats:sub> cotreatment. Mechanistically, the ADR-induced c-Jun N-terminal kinase\/stress-activated protein kinase (JNK\/SAPK) phosphorylation, inhibited by HG, was efficiently restored by ZnCl<jats:sub>2<\/jats:sub>. The JNK involvement in apoptotic cell death was assessed by the use of JNK dominant-negative expression vector that indeed impaired the ZnCl<jats:sub>2<\/jats:sub> ability to restore drug-induced cell death in HG condition. Altogether, these findings indicate that ZnCl<jats:sub>2<\/jats:sub> supplementation efficiently restored the drug-induced cancer cell death, inhibited by HG, by both sustaining JNK activation and counteracting the glycolytic pathway.<\/jats:p>","DOI":"10.1038\/cddis.2016.178","type":"journal-article","created":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T13:05:05Z","timestamp":1467291905000},"page":"e2280-e2280","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["ZnCl2 sustains the adriamycin-induced cell death inhibited by high glucose"],"prefix":"10.1038","volume":"7","author":[{"given":"A","family":"Garufi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Trisciuoglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Cirone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"D'Orazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,30]]},"reference":[{"key":"BFcddis2016178_CR1","doi-asserted-by":"publisher","first-page":"461917","DOI":"10.1155\/2014\/461917","volume":"2014","author":"W Duan","year":"2014","unstructured":"Duan W, Shen X, Lei J, Xu Q, Yu Y, Li R et al. Hyperglycemia, a neglected factor during cancer progression. BioMed Res Int 2014; 2014: 461917.","journal-title":"BioMed Res Int"},{"key":"BFcddis2016178_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1126\/science.1089999","volume":"4176","author":"R Dobbs","year":"1975","unstructured":"Dobbs R, Sakurai H, Sasaki H . Glucagon: role in the hyperglycemia of diabetes mellitus. Science 1975; 4176: 544\u2013547.","journal-title":"Science"},{"key":"BFcddis2016178_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/ALN.0b013e3181799d45","volume":"109","author":"JA Martyn","year":"2008","unstructured":"Martyn JA, Kaneki M, Yasuhara S . Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms. Anesthesiology 2008; 109: 137\u2013148.","journal-title":"Anesthesiology"},{"key":"BFcddis2016178_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/MD.0000000000002382","volume":"95","author":"JIC Kennedy","year":"2016","unstructured":"Kennedy JIC, Askelund KJ, Premkumar R, Phillips ARJ, Murphy R, Windsor JA et al. Leptin is associated with persistence of hyperglycemia in acute pancreatitis: a prospective clinical study. Medicine 2016; 95: 6.","journal-title":"Medicine"},{"key":"BFcddis2016178_CR5","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/MOG.0000000000000199","volume":"31","author":"JJ Meier","year":"2015","unstructured":"Meier JJ, Giese A . Diabetes associated with pancreatic diseases. Curr Opin Gastroenterol 2015; 31: 400\u2013406.","journal-title":"Curr Opin Gastroenterol"},{"key":"BFcddis2016178_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/0148607106030002157","volume":"30","author":"JI Mechanick","year":"2006","unstructured":"Mechanick JI . Metabolic mechanisms of stress hyperglycemia. J Parent Enter Nutr 2006; 30: 157\u2013163.","journal-title":"J Parent Enter Nutr"},{"key":"BFcddis2016178_CR7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.4093\/dmj.2014.38.5.330","volume":"38","author":"TY Ryu","year":"2014","unstructured":"Ryu TY, Park JY, Schere PE . Hyperglycemia as a risk factor for cancer progression. Diabetes Metab J 2014; 38: 330\u2013336.","journal-title":"Diabetes Metab J"},{"key":"BFcddis2016178_CR8","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1677\/ERC-09-0221","volume":"17","author":"L Zeng","year":"2010","unstructured":"Zeng L, Biernacka KM, Holly JM, Jarrett C, Morrison AA, Morgan A et al. Hyperglicaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase. Endocr Relat Cancer 2010; 17: 539\u2013551.","journal-title":"Endocr Relat Cancer"},{"key":"BFcddis2016178_CR9","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1093\/jnci\/djs399","volume":"104","author":"JA Meyerhardt","year":"2012","unstructured":"Meyerhardt JA, Sato K, Niedzwiecki D, Ye C, Saltz LB, Mayer RJ et al. Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Natl Cancer Inst 2012; 104: 1702\u20131711.","journal-title":"J Natl Cancer Inst"},{"key":"BFcddis2016178_CR10","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1530\/ERC-13-0077","volume":"20","author":"KM Biernacka","year":"2013","unstructured":"Biernacka KM, Uzoh CC, Zeng L, Persad RA, Bahl A, Gillatt D et al. Hyperglicaemia-induced chemoresistance of prostate cancer cells due to IGFBP2. Endocr Relat Cancer 2013; 20: 741\u2013751.","journal-title":"Endocr Relat Cancer"},{"key":"BFcddis2016178_CR11","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/mc.21922","volume":"52","author":"NK Vishvakarma","year":"2013","unstructured":"Vishvakarma NK, Kumar A, Singh V, Singh SM . Hyperglycemia of tumor microenvironment modulates stage-dependent tumor progression and multidrug resistance: implication of cell survival regulatory molecules and altered glucose transport. Mol Carcinog 2013; 52: 932\u2013945.","journal-title":"Mol Carcinog"},{"key":"BFcddis2016178_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1089\/dna.2013.2161","volume":"33","author":"YS Ma","year":"2014","unstructured":"Ma YS, Yang IP, Tsai HL, Huang CW, Juo SH, Wang JY . High glucose modulates antiproliferative effect and cytotoxicity of 5-Fluorouracil in human colon cancer cells. DNA Cell Biol 2014; 33: 64\u201372.","journal-title":"DNA Cell Biol"},{"key":"BFcddis2016178_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.18632\/aging.100871","volume":"8","author":"G Pistritto","year":"2016","unstructured":"Pistritto G, Trisciuoglio D, Ceci C, Garufi A, D\u2019Orazi G . Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging-US 2016; 8: 3.","journal-title":"Aging-US"},{"key":"BFcddis2016178_CR14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/ijc.24064","volume":"124","author":"S Fulda","year":"2009","unstructured":"Fulda S . Tumor resistance to apoptosis. Int J Cancer 2009; 124: 515\u2013515.","journal-title":"Int J Cancer"},{"key":"BFcddis2016178_CR15","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646\u2013674.","journal-title":"Cell"},{"key":"BFcddis2016178_CR16","first-page":"l","volume":"5","author":"L Gianni","year":"1983","unstructured":"Gianni L, Corden BJ, Myers CE . The bio-chemical basis of anthracycline toxicity and antitumoraction. Rev Biochem Toxicol 1983; 5: l\u201382.","journal-title":"Rev Biochem Toxicol"},{"key":"BFcddis2016178_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000086183","volume":"14","author":"YA Luqmani","year":"2005","unstructured":"Luqmani YA . Mechanisms of drug resistance in cancer chemotherapy. Med Princ Pract 2005; 14: 35\u201348.","journal-title":"Med Princ Pract"},{"key":"BFcddis2016178_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0304-3835(96)04345-5","volume":"107","author":"R Yu","year":"1996","unstructured":"Yu R, Shtil AA, Tan TH, Roninsonb IB, Kong AN . Adriamycin activates c-jun N-terminal kinase in human leukemia cells: a relevance to apoptosis. Cancer Lett 1996; 107: 73\u201381.","journal-title":"Cancer Lett"},{"key":"BFcddis2016178_CR19","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s10495-006-7494-8","volume":"11","author":"F Li","year":"2006","unstructured":"Li F, Meng L, Xing H, Zhou J, Wang S, Huang L et al. Essential role of c-Jun-NH2-terminal kinase on synergy induction of apoptosis by TRAIL plus ADM in ADM resistant MCF-7\/ADM cells. Apoptosis 2006; 11: 1239\u20131246.","journal-title":"Apoptosis"},{"key":"BFcddis2016178_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ccr.2006.05.012","volume":"9","author":"T Bui","year":"2006","unstructured":"Bui T, Thompson CB . Cancer\u2019s sweet tooth. Cancer Cell 2006; 9: 419\u2013420.","journal-title":"Cancer Cell"},{"key":"BFcddis2016178_CR21","doi-asserted-by":"publisher","first-page":"e639","DOI":"10.1038\/cddis.2013.163","volume":"4","author":"A Garufi","year":"2013","unstructured":"Garufi A, Ricci A, Trisciuoglio D, Iorio E, Carpinelli G, Pistritto G et al. Glucose restriction induces cell death in parental but not in homeodomain-interacting protein kinase 2-depleted RKO colon cancer cells: molecular mechanisms and therapeutical implications. Cell Death Dis 2013; 4: e639.","journal-title":"Cell Death Dis"},{"key":"BFcddis2016178_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrc2981","volume":"11","author":"RA Cairns","year":"2011","unstructured":"Cairns RA, Harris IS, Mak TW . Regulation of cancer cell metabolism. Nat Rev Cancer 2011; 11: 85\u201395.","journal-title":"Nat Rev Cancer"},{"key":"BFcddis2016178_CR23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1476-4598-12-152","volume":"12","author":"S Ganapathy-Kanniappan","year":"2013","unstructured":"Ganapathy-Kanniappan S, Geschwind JF . Tumor glycolysis as a target for cancer therapy: progress and prospect. Mol Cancer 2013; 12: 152.","journal-title":"Mol Cancer"},{"key":"BFcddis2016178_CR24","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/j.1742-4658.2007.05686.x","volume":"274","author":"R Moreno-S\u00e1nchez","year":"2007","unstructured":"Moreno-S\u00e1nchez R, Rodr\u00edguez-Enr\u00edquez S, Mar\u00edn-Hern\u00e1ndez A, Saavedra E . Energy metabolism in tumor cells. FEBS J 2007; 274: 1393\u20131418.","journal-title":"FEBS J"},{"key":"BFcddis2016178_CR25","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1517\/14728220903307509","volume":"13","author":"T Amann","year":"2009","unstructured":"Amann T, Hellerbrand C . GLUT1 as a therapeutic target in hepatocellular carcinoma. Expert Opin Ther Targets 2009; 13: 1411\u20131427.","journal-title":"Expert Opin Ther Targets"},{"key":"BFcddis2016178_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/1471-2407-9-241","volume":"9","author":"FY Chung","year":"2009","unstructured":"Chung FY, Huang MY, Yeh CS, Chang HJ, Cheng TL, Yen LC et al. GLUT1 gene is a potential hypoxic marker in colorectal cancer patients. BMC Cancer 2009; 9: 241.","journal-title":"BMC Cancer"},{"key":"BFcddis2016178_CR27","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.7314\/APJCP.2014.15.4.1823","volume":"15","author":"K Song","year":"2014","unstructured":"Song K, Li M, Xuan L, Huang GN, Song XL, Liu QF . HIF-1\u03b1 and GLUT1 gene expression is associated with chemoresistance of acute myeloid leukemia. Asian Pac J Cancer Prev 2014; 15: 1823\u20131829.","journal-title":"Asian Pac J Cancer Prev"},{"key":"BFcddis2016178_CR28","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1593\/neo.04430","volume":"7","author":"IF Robey","year":"2005","unstructured":"Robey IF, Lien AD, Welsh SJ, Baggett BK, Gillies RJ . Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors. Neoplasia 2005; 7: 324\u2013330.","journal-title":"Neoplasia"},{"key":"BFcddis2016178_CR29","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/onc.2009.441","volume":"29","author":"GL Semenza","year":"2010","unstructured":"Semenza GL . Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 2010; 29: 625\u2013634.","journal-title":"Oncogene"},{"key":"BFcddis2016178_CR30","doi-asserted-by":"publisher","first-page":"F1065","DOI":"10.1152\/ajprenal.00381.2007","volume":"294","author":"WS Yang","year":"2008","unstructured":"Yang WS, Seo JW, Han NJ, Choi J, Lee KU, Ahn H et al. High glucose-induced NF-kB activation occurs via tyrosine phosphorylation of IkBa in human glomerular endothelial cells: involvement of Syk tyrosine kinase. Am J Physiol Renal Physiol 2008; 294: F1065\u2013F1075.","journal-title":"Am J Physiol Renal Physiol"},{"key":"BFcddis2016178_CR31","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/ni.2060","volume":"12","author":"Y Ben-Neriah","year":"2011","unstructured":"Ben-Neriah Y, Karin M . Inflammation meets cancer, with NF-kB as the match maker. Nat Immunol 2011; 12: 715\u2013723.","journal-title":"Nat Immunol"},{"key":"BFcddis2016178_CR32","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/sj.cdd.4401865","volume":"13","author":"S Papa","year":"2006","unstructured":"Papa S, Bubici C, Zazzeroni F, Pham CG, Kuntzen C, Knabb JR et al. The NF-kB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death Diff 2006; 13: 712\u2013729.","journal-title":"Cell Death Diff"},{"key":"BFcddis2016178_CR33","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.18632\/oncotarget.395","volume":"2","author":"M Sheffer","year":"2011","unstructured":"Sheffer M, Simon AJ, Jacob-Hirsch J, Rechavi G, Domany E, Givol D et al. Genome-wide analysis discloses complete reversion of the hypoxia-induced transcription by zinc in colon cancer cells. Oncotarget 2011; 2: 1191\u20131202.","journal-title":"Oncotarget"},{"key":"BFcddis2016178_CR34","doi-asserted-by":"publisher","first-page":"e6819","DOI":"10.1371\/journal.pone.0006819","volume":"4","author":"L Nardinocchi","year":"2009","unstructured":"Nardinocchi L, Puca R, Sacchi A, Rechavi G, Givol D, D\u2019Orazi G . Targeting hypoxia in cancer cells by restoring homeodomain interacting protein kinase 2 and p53 activity and suppressing HIF-1alpha. PLoS One 2009; 4: e6819.","journal-title":"PLoS One"},{"key":"BFcddis2016178_CR35","doi-asserted-by":"publisher","first-page":"e15048","DOI":"10.1371\/journal.pone.0015048","volume":"5","author":"L Nardinocchi","year":"2010","unstructured":"Nardinocchi L, Pantisano P, Puca R, Porru M, Aiello A, Grasselli A et al. Zinc downregulates HIF-1\u03b1 and inhibits its activity in tumor cells in vitro and in vivo. PLoS One 2010; 5: e15048.","journal-title":"PLoS One"},{"key":"BFcddis2016178_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13046-014-0079-4","volume":"33","author":"A Garufi","year":"2014","unstructured":"Garufi A, D\u2019Orazi G . High glucose dephosphorylates serine 46 and inhibits p53 apoptotic activity. J Exp Clin Cancer Res 2014; 33: 79.","journal-title":"J Exp Clin Cancer Res"},{"key":"BFcddis2016178_CR37","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/371346a0","volume":"371","author":"YA Lazebnik","year":"1994","unstructured":"Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC . Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994; 371: 346\u2013347.","journal-title":"Nature"},{"key":"BFcddis2016178_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/0008-5472.CAN-03-3294","volume":"64","author":"G Maschek","year":"2004","unstructured":"Maschek G, Savaraj N, Priebe W, Braunschweiger P, Hamilton K, Tidmarsh GF et al. 2-deoxy-D-glucose increases the efficacy of adryamicin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo. Cancer Res 2004; 64: 31\u201334.","journal-title":"Cancer Res"},{"key":"BFcddis2016178_CR39","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-09-2782","volume":"70","author":"IB Sahra","year":"2010","unstructured":"Sahra IB, Laurent K, Giuliano S, Larbret F, Ponzio G, Gounon P et al. Targeting cancer cell metabolism. The combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells. Cancer Res 2010; 70: 2465\u20132475.","journal-title":"Cancer Res"},{"key":"BFcddis2016178_CR40","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1093\/embo-reports\/kve223","volume":"11","author":"S Sciortino","year":"2001","unstructured":"Sciortino S, Gurtner A, Manni I, Fontemaggi G, Dey A, Sacchi A et al. The cyclin B1 gene is actively transcribed during mitosis in HeLa cells. EMBO Rep 2001; 11: 1018\u20131023.","journal-title":"EMBO Rep"},{"key":"BFcddis2016178_CR41","doi-asserted-by":"publisher","first-page":"19245","DOI":"10.1074\/jbc.M208134200","volume":"278","author":"A Mansouri","year":"2003","unstructured":"Mansouri A, Ridgway LD, Korapati AL, Zhang Q, Tian L, Wang Y et al. Sustained activation of JNK\/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. J Biol Chem 2003; 278: 19245\u201319256.","journal-title":"J Biol Chem"},{"key":"BFcddis2016178_CR42","doi-asserted-by":"publisher","first-page":"10110","DOI":"10.1074\/jbc.272.15.10110","volume":"272","author":"L Butterfield","year":"1997","unstructured":"Butterfield L, Storey B, Maas L, Heasley LE . C-Jun NH2-terminal kinase regulation of the apoptotic response of small cell lung cancer cells to ultraviolet radiation. J Biol Chem 1997; 272: 10110\u201310116.","journal-title":"J Biol Chem"},{"key":"BFcddis2016178_CR43","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1083\/jcb.151.4.801","volume":"151","author":"A Paasinen-Sohns","year":"2000","unstructured":"Paasinen-Sohns A, Kielosto M, K\u00e4\u00e4ri\u00e4inen E, Eloranta T, Laine A, J\u00e4nne OA et al. c-Jun activation-dependent tumorigenic transformation induced paradoxically by overexpression or block of S-Adenosylmethionine decarboxylase. J Cell Biol 2000; 151: 801\u2013809.","journal-title":"J Cell Biol"},{"key":"BFcddis2016178_CR44","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1128\/MCB.01219-06","volume":"27","author":"CG Pham","year":"2007","unstructured":"Pham CG, Bubici C, Zazzeroni F, Knabb JR, Papa S, Kuntzen C et al. Upregulation of Twist-1 by NF-kB blocks cytotoxicity induced by chemotherapeutic drugs. Mol Cell Biol 2007; 27: 3920\u20133935.","journal-title":"Mol Cell Biol"},{"key":"BFcddis2016178_CR45","doi-asserted-by":"publisher","first-page":"36344","DOI":"10.1074\/jbc.M803580200","volume":"283","author":"Y Zhao","year":"2008","unstructured":"Zhao Y, Coloff JL, Ferguson EC, Jacobs SR, Cui K, Rathmell JC . Glucose metabolism attenuates p53 and Puma-dependent cell death upon growth factor deprivation. J Biol Chem 2008; 283: 36344\u201336353.","journal-title":"J Biol Chem"},{"key":"BFcddis2016178_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.biocel.2014.04.014","volume":"51","author":"C Cencioni","year":"2014","unstructured":"Cencioni C, Spallotta F, Greco S, Martelli F, Zeiher AM, Gaetano C . Epigenetic mechanisms of hyperglycemic memory. Int J Biochem Cell Biol 2014; 51: 155\u2013158.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFcddis2016178_CR47","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","volume":"92","author":"GL Wang","year":"1995","unstructured":"Wang GL, Jiang B-H, Rue EA, Semenza GL . Hypoxia-inducible factor 1 is a basic-helix\u2013loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995; 92: 5510\u20135514.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2016178_CR48","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.bbamcr.2008.10.013","volume":"1793","author":"L Nardinocchi","year":"2009","unstructured":"Nardinocchi L, Puca R, Guidolin D, Belloni AS, Bossi G, Michiels C et al. Transcriptional regulation of hypoxia-inducible factor 1\u03b1 by HIPK2 suggests a novel mechanism to restrain tumor growth. Biochim Biophys Acta 2009; 1793: 368\u2013377.","journal-title":"Biochim Biophys Acta"},{"key":"BFcddis2016178_CR49","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000207505","volume":"76","author":"Y Hiyoshi","year":"2009","unstructured":"Hiyoshi Y, Watanabe M, Imamura Y, Nagai Y, Baba Y, Yoshida N et al. The relationship between the glucose transporter type 1 expression and Ffluorodeoxyglucose uptake in esophageal squamous cell carcinoma. Oncology 2009; 76: 286\u2013292.","journal-title":"Oncology"},{"key":"BFcddis2016178_CR50","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00280-006-0291-9","volume":"59","author":"X Cao","year":"2007","unstructured":"Cao X, Fang L, Gibbs S, Huang Y, Dai Z, Wen P, et al. Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia. Cancer Chemother Pharmacol 2007; 59: 495\u2013505.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFcddis2016178_CR51","doi-asserted-by":"publisher","first-page":"e23205","DOI":"10.1371\/journal.pone.0023205","volume":"6","author":"CD Young","year":"2011","unstructured":"Young CD, Lewis AS, Rudolph MC, Ruehle MD, Jackman MR, Yun UJ et al. Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo. PLoS One 2011; 6: e23205.","journal-title":"PLoS One"},{"key":"BFcddis2016178_CR52","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/156482651303400210","volume":"34","author":"M Ruz","year":"2013","unstructured":"Ruz M, Carrasco F, Rojas P, Codoceo J, Inostroza J, Basfi-fer K et al. Zinc as a potential coadjuvant in therapy for type 2 diabetes. Food Nutr Bull 2013; 34: 215\u2013221.","journal-title":"Food Nutr Bull"},{"key":"BFcddis2016178_CR53","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.toxlet.2006.07.306","volume":"166","author":"B Bao","year":"2006","unstructured":"Bao B, Prasad A, Becka FWJ, Suneja A, Sark F . Toxic effect of zinc on NF-kB, IL-2, IL-2. receptor \u03b1, and TNF-\u03b1 in HUT-78 (Th0) cells. Toxicol Lett 2006; 166: 222\u2013228.","journal-title":"Toxicol Lett"},{"key":"BFcddis2016178_CR54","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1080\/01635580903285122","volume":"61","author":"AS Prasda","year":"2009","unstructured":"Prasda AS, Beck FWJ, Snell DC, Kucuk O . Zinc in cancer prevention. Nutr Cancer 2009; 61: 879\u2013887.","journal-title":"Nutr Cancer"},{"key":"BFcddis2016178_CR55","doi-asserted-by":"publisher","first-page":"E562","DOI":"10.1002\/ijc.26441","volume":"131","author":"O Margalit","year":"2012","unstructured":"Margalit O, Simon AJ, Yabukov E, Puca R, Yosepovich A, Avivi C et al. Zinc supplement augments in vivo antitumor effect of chemotherapy by restoring p53 function. Int J Cancer 2012; 131: E562\u2013E568.","journal-title":"Int J Cancer"},{"key":"BFcddis2016178_CR56","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.4161\/cc.29334","volume":"13","author":"CK Singh","year":"2014","unstructured":"Singh CK, Pitschmann A, Ahmad N . Resveratrol-zinc combination for prostate cancer management. Cell Cycle 2014; 13: 1867\u20131874.","journal-title":"Cell Cycle"},{"key":"BFcddis2016178_CR57","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1158\/1535-7163.MCT-13-0944","volume":"13","author":"JM Arriaga","year":"2014","unstructured":"Arriaga JM, Greco A, Mordoh J, Bianchini M . Metallothionein 1G and zinc sensitize human colorectal cancer cells to chemotherapy. Mol Cancer Ther 2014; 13: 1369\u20131381.","journal-title":"Mol Cancer Ther"},{"key":"BFcddis2016178_CR58","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.ejca.2013.12.027","volume":"50","author":"JL Gu","year":"2014","unstructured":"Gu JL, Wang B, Liu YA, Zhong LZ, Tang YF, Guo H et al. Murine double minute 2 siRNA and wild-type p53 gene therapy interact positively with zinc on prostate tumours in vitro and in vivo. Eur J Cancer 2014; 50: 1184\u20131194.","journal-title":"Eur J Cancer"},{"key":"BFcddis2016178_CR59","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.2147\/DDDT.S87662","volume":"9","author":"H Kocdor","year":"2015","unstructured":"Kocdor H, Ates H, Aydin S, Cehreli R, Soyarat F, Kemanli P et al. Zinc supplementation induces apoptosis and enhances antitumor efficacy of docetaxel in non-small-cell lung cancer. Drug Des Dev Ther 2015; 9: 3899\u20133909.","journal-title":"Drug Des Dev Ther"},{"key":"BFcddis2016178_CR60","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3892\/ijo.2015.3125","volume":"47","author":"A Garufi","year":"2015","unstructured":"Garufi A, D\u2019Orazi V, Crispini A, D\u2019Orazi G . Zn(II)-curc targets p53 in thyroid cancer cells. Int J Oncol 2015; 47: 1241\u20131248.","journal-title":"Int J Oncol"},{"key":"BFcddis2016178_CR61","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13046-015-0206-x","volume":"34","author":"A Garufi","year":"2015","unstructured":"Garufi A, Ubertini V, Mancini F, D\u2019Orazi V, Baldari S, Moretti F et al. The beneficial effect of Zinc(II) on low-dose chemotherapeutic sensitivity involves p53 activation in wild-type p53 cancer cells. J Exp Clin Cancer Res 2015; 34: 87.","journal-title":"J Exp Clin Cancer Res"},{"key":"BFcddis2016178_CR62","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1021\/acs.jafc.5b04924","volume":"64","author":"WZ Liao","year":"2016","unstructured":"Liao WZ, Lai T, Chen LY, Fu JN, Sreenivasan ST, Yu ZQ et al. Synthesis and characterization of a walnut peptides-zinc complex and its antiproliferative activity against human breast carcinoma cells through the induction of apoptosis. J Agric Food Chem 2016; 64: 1509\u20131519.","journal-title":"J Agric Food Chem"},{"key":"BFcddis2016178_CR63","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/sj.cdd.4400594","volume":"6","author":"PG Ekert","year":"1999","unstructured":"Ekert PG, Silke J, Vaux DL . Caspase inhibitors. Cell Death Diff 1999; 6: 1081\u20131086.","journal-title":"Cell Death Diff"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2016178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2016178","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2016178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T08:58:46Z","timestamp":1672822726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2016178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,30]]},"references-count":63,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6]]}},"alternative-id":["BFcddis2016178"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2016.178","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,30]]},"assertion":[{"value":"23 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}